Péter Hauser

15.8k total citations
75 papers, 1.9k citations indexed

About

Péter Hauser is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Péter Hauser has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 18 papers in Molecular Biology and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Péter Hauser's work include Glioma Diagnosis and Treatment (19 papers), Childhood Cancer Survivors' Quality of Life (13 papers) and Neuroblastoma Research and Treatments (11 papers). Péter Hauser is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Childhood Cancer Survivors' Quality of Life (13 papers) and Neuroblastoma Research and Treatments (11 papers). Péter Hauser collaborates with scholars based in Hungary, United States and Germany. Péter Hauser's co-authors include Miklós Garami, Mitchel A. Kling, Robert M. Post, Joel Gelernter, László Bognár, Wade H. Berrettini, J. Richard Hebel, Douglas D. Bradham, David Barrett and Paul E. Ruskin and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Psychiatry and Clinical Infectious Diseases.

In The Last Decade

Péter Hauser

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Hauser Hungary 24 577 476 319 270 249 75 1.9k
Amy M. Shui United States 29 255 0.4× 206 0.4× 683 2.1× 111 0.4× 359 1.4× 140 3.0k
Melanie E. Garrett United States 25 660 1.1× 644 1.4× 311 1.0× 125 0.5× 35 0.1× 93 2.5k
Prashni Paliwal United States 26 449 0.8× 435 0.9× 167 0.5× 161 0.6× 77 0.3× 38 3.3k
Arthur R. Van Gool Netherlands 26 184 0.3× 127 0.3× 392 1.2× 159 0.6× 39 0.2× 71 2.1k
Jason C. Simeone United States 19 254 0.4× 304 0.6× 194 0.6× 50 0.2× 567 2.3× 40 1.8k
Jonathan Greenberg United States 24 196 0.3× 51 0.1× 260 0.8× 155 0.6× 122 0.5× 133 2.2k
Dana Erickson United States 28 154 0.3× 393 0.8× 366 1.1× 40 0.1× 250 1.0× 116 3.2k
Shing Wan Choi United Kingdom 15 644 1.1× 47 0.1× 327 1.0× 176 0.7× 98 0.4× 24 2.6k
John V. Conaglen New Zealand 27 650 1.1× 139 0.3× 262 0.8× 103 0.4× 101 0.4× 88 2.4k
Emily C. Martin United States 18 131 0.2× 171 0.4× 201 0.6× 515 1.9× 86 0.3× 47 1.8k

Countries citing papers authored by Péter Hauser

Since Specialization
Citations

This map shows the geographic impact of Péter Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Hauser more than expected).

Fields of papers citing papers by Péter Hauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Hauser. The network helps show where Péter Hauser may publish in the future.

Co-authorship network of co-authors of Péter Hauser

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Hauser. A scholar is included among the top collaborators of Péter Hauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Hauser. Péter Hauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szabados, Márton, et al.. (2025). Dinutuximab Beta for the Treatment of High-Risk Neuroblastoma: Data from the Hungarian Pediatric Oncology Network. Journal of Clinical Medicine. 14(18). 6641–6641.
2.
3.
Castor, Charlotte, Radek Frič, Péter Hauser, et al.. (2025). Postoperative word-finding difficulties in children with posterior fossa tumours: a crosslinguistic European cohort study. Child s Nervous System. 41(1). 128–128.
4.
Dóczi, Róbert, István Szegedi, Réka Simon, et al.. (2023). Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors. World Journal of Pediatrics. 19(10). 992–1008. 1 indexed citations
5.
Hauser, Péter, et al.. (2021). Isolated Hallucination as a Consequence of SARS-CoV-2 Infection in a 10-year-old Child. Clinical Child Psychology and Psychiatry. 27(1). 238–243. 2 indexed citations
6.
Jakab, Zsuzsanna, Miklós Garami, Monika Csóka, et al.. (2020). Late mortality in survivors of childhood cancer in Hungary. Scientific Reports. 10(1). 10761–10761. 4 indexed citations
7.
Hegedüs, Katalin, et al.. (2018). The timing and circumstances of the implementation of pediatric palliative care in Hungarian pediatric oncology. European Journal of Pediatrics. 177(8). 1173–1179. 12 indexed citations
8.
Pócza, Tímea, et al.. (2016). High expression of DNA methyltransferases in primary human medulloblastoma. Folia Neuropathologica. 2(2). 105–113. 9 indexed citations
9.
Ryan, Sarra, Ed C. Schwalbe, Michael Cole, et al.. (2011). MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathologica. 123(4). 501–513. 65 indexed citations
10.
Al-Halabi, H., André Nantel, Álmos Klekner, et al.. (2010). Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathologica. 121(2). 229–239. 32 indexed citations
11.
Loftis, Jennifer M., et al.. (2008). Depression Comorbidity and Antidepressant Use in Veterans With Chronic Hepatitis C. The Journal of Clinical Psychiatry. 69(5). 810–816. 36 indexed citations
12.
Hanzély, Zoltán, et al.. (2008). A szomatosztatinreceptor-expresszió változásának vizsgálata recidiváló medulloblastomában. PubMed. 52(4). 351–355. 1 indexed citations
13.
Hauser, Péter, et al.. (2007). Advanced Pediatric Inoperable Thymus Carcinoma (Type C Thymoma): Case Report on a Novel Therapeutic Approach. Journal of Pediatric Hematology/Oncology. 29(11). 774–775. 7 indexed citations
14.
Garami, Miklós, Dezső Schuler, Gábor Borgulya, et al.. (2004). Fermented Wheat Germ Extract Reduces Chemotherapy-Induced Febrile Neutropenia in Pediatric Cancer Patients. Journal of Pediatric Hematology/Oncology. 26(10). 631–635. 35 indexed citations
15.
Dobscha, Steven K., et al.. (2003). Strategies to Decrease Costs of Prescribing Selective Serotonin Reuptake Inhibitors at a VA Medical Center. Psychiatric Services. 54(2). 195–200. 14 indexed citations
16.
Hauser, Péter, Zsuzsanna Jakab, Orsolya Láng, et al.. (2003). High incidence of brain tumors of childhood in Hungary between 1989 and 2001. Medical and Pediatric Oncology. 41(6). 590–591. 6 indexed citations
17.
Garami, Miklós, et al.. (2000). [Survival of Ewing' s sarcoma patients in Hungary]. PubMed. 44(4). 261–264. 1 indexed citations
18.
Hauser, Péter & Joanne Rovet. (1999). Thyroid diseases of infancy and childhood : effects on behavior and intellectual development. 4 indexed citations
19.
Zalatnai, Attila, et al.. (1999). Epithelial mesothelioma with deciduoid features. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 434(3). 263–266. 28 indexed citations
20.
Hauser, Péter. (1989). Benzodiazepine Withdrawal Delirium With Catatonic Features. Archives of Neurology. 46(6). 696–696. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026